Skip to content

Arrowhead Pharmaceuticals, Inc.

ARWR· NasdaqCore metricsCIK 879407

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -4.50%
Market cap
$6.66B
141.37M shares
Filings
1,014
$450.82M
FY 2026−45.6% FY26 yoy
-$724.21M
FY 2026N/M FY26 yoy
-$707.17M
FY 2026N/M FY26 yoy
-$283.94M
FY 2026derivedN/M FY26 yoy
-$5.11
FY 2026N/M FY26 yoy
$62.74M
FY 2026−72.3% FY26 yoy
$6.66B
—
14.8×
132.4×
-4.26%
—

Twelve months to Sep 30, 2026 · derived

Price

$47.14+13.55%+$5.63past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$450.82MFY 2026
$829.45M0FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-09-30$450,817,000reported
FY 20252025-09-30$829,448,000reported
FY 20242024-09-30$3,551,000reported
FY 20232023-09-30$240,735,000reported
FY 20222022-09-30$243,231,000reported
FY 20212021-09-30$138,287,000reported
FY 20202020-09-30$87,992,000reported
FY 20192019-09-30$168,796,000reported
FY 20182018-09-30$16,142,321reported
FY 20172017-09-30$31,407,709reported
FY 20162016-09-30$158,333reported
FY 20152015-09-30$382,000reported

Segments

Products
Revenue by Products, FY2024 to FY2026FY2024Collaboration and license revenue · FY2024 · $3.55MFY2025Collaboration and license revenue · FY2025 · $829.45MFY2026Collaboration and license revenue · FY2026 · $444.21MProduct revenue, net · FY2026 · $6.60M
LineFY2026ShareChange
Collaboration and license revenue$444.21M99%−46.4%
Product revenue, net$6.60M1.5%—
Total$450.82M

From the 10-K filed Nov 12, 2026ARWR

Pharmaceutical preparations

Arrowhead Pharmaceuticals, Inc. is the 59th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Arrowhead Pharmaceuticals, Inc. · CIK 879407 · Engraved from SEC EDGAR